http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#head http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#provenance http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://rdf.disgenet.org/resource/gda/DGN4b74b2b800a2386c1f64046273793c7b http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/2099 http://rdf.disgenet.org/resource/gda/DGN4b74b2b800a2386c1f64046273793c7b http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0678222 http://rdf.disgenet.org/resource/gda/DGN4b74b2b800a2386c1f64046273793c7b http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#provenance http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://purl.org/dc/terms/description [We analyzed three series of de novo stage II-III breast cancer patients treated front line with anthracycline-based regimens of various cyclophosphamide dose intensities: 65 patients with estrogen receptor (ER)(-) tumors treated with anthracyclines alone (Institut Jules Bordet, Brussels), 51 unselected breast cancer patients treated with intermediate doses of cyclophosphamide (MD Anderson Cancer Center, Houston, TX), and 128 others treated with a dose-dense anthracycline-cyclophosphamide combination (St. Louis, Paris).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/20228131 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/dc/terms/created 2017-10-17T13:12:30+02:00 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP366185.RAe6xqdnxrPKWT9eULNqBupL-TbOm14bPpzJUQgKF_MWU http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0